Viewing Study NCT02824094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-03-02 @ 4:24 PM
Study NCT ID: NCT02824094
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2017-07-21
First Post: 2016-06-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Crizotinib Expanded Access Protocol For ROS1 Positive NSCLC
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Expanded Access Protocol View
None crizotinib View
None Xalkori View
None ROS1 View
None Japanese View
None A8081064 View